National Cancer InstituteU.S. National Institutes of Healthwww.cancer.gov
Center to Reduce Cancer Health Disparities logo

Staff Biography

Lionel L. Bañez, M.D.

Center to Reduce Cancer Health Disparities
National Cancer Institute
9609 Medical Center Drive, MSC 9746
Sixth Floor, West Tower, 6W254
Rockville, MD 20852
phone: (240) 276-7009
fax: (240) 276-7862
email: banezll@mail.nih.gov

Dr. Lionel L. Bañez is a Program Director in the Diversity Research Branch within the Center to Reduce Cancer Health Disparities (CRCHD) at the National Cancer Institute (NCI). In this role, Dr. Bañez oversees national and regional Community Network Program Centers (CNPC) supported by NCI to improve access and utilization of biomedical knowledge and behavioral procedures designed to reduce cancer disparities among underserved populations including racial minorities. He also oversees grant mechanisms for research focused on reducing cancer health disparities and co-manages supplements for the Geographical Management of Cancer Health Disparities (GMaP) and the Diversity Supplement portfolio.

Prior to his appointment at NCI, Dr. Bañez was an Assistant Professor at Duke University where he conducted clinical, epidemiological and translational research on prostate cancer. His research interests include prostate cancer health disparity, early detection, risk assessment, and biomarkers. He is a recipient of a Department of Defense Health Disparity Research Award for his work on obesity-related hemodilution of PSA and other cancer markers. He has served both as a Scientist Reviewer for the Congressionally Directed Medical Research Program (CDMRP) of the Department of Defense and as a Scientific Review Officer for SRA International, Inc. He was also a Staff Scientist at the Center for Prostate Disease Research, Uniformed Services University of the Health Sciences (CPDR-USUHS).

Dr. Bañez received his M.D. from the University of the Philippines College of Medicine and residency training in General Surgery at the University of the Philippines - Philippine General Hospital. He underwent a basic science and translational postdoctoral fellowship at CPDR-USUHS and a clinical research fellowship at Duke University.



Select Publications and Presentations

Bañez LL, Hamilton RJ, Partin AW, et al. Obesity-Related Plasma Hemodilution and PSA Concentration among Men with Prostate Cancer. JAMA, 298(19):2275-80, 2007.

Bañez LL, Terris MK, Aronson WJ, et al. Race and Time from Diagnosis to Radical Prostatectomy: Does Equal Access Mean Equal Timely Access to the Operating Room?–Results from the SEARCH Database. Cancer Epidemiol Biomarkers Prev. 18(4):1208-12; 2009.

Bañez LL, Sun L, Trock BJ, et al. Body Mass Index and Prostate-Specific Antigen as a Predictor of Adverse Pathology and Biochemical Recurrence Following Radical Prostatectomy. J Urol. 182(2):491-6; 2009.

Jayachandran J, Bañez LL, Aronson WJ, et al. Obesity as a Predictor of Biochemical Recurrence across Black and White Race: Results from the SEARCH Database. Cancer. 115(22):5263-71; 2009.

Bañez LL, Klink JC, Jayachandran J, et al. Association between Statins and Prostate Tumor Inflammatory Infiltrate in Men Undergoing Radical Prostatectomy. Cancer Epidemiol Biomarkers Prev. 2010;19(3):722-8.

Bañez LL, Sun L, Leenders GJ, et al. Multicenter Clinical Validation of PITX2 Methylation as a Prostate Specific Antigen Recurrence Predictor in Patients With Post-Radical Prostatectomy Prostate Cancer. J Urol. 184(1):149-56, 2010.

Chu DI, De Nunzio C, Gerber L, Thomas II JA, Calloway EE, AlbisinniS , Senocak C, McKeever MG, Moreira DM, Tubaro A, Moul JW, Freedland SJ, and Bañez LL. Predictive Value of Digital Rectal Examination for Prostate Cancer Detection is Modified by Obesity. Prostate Cancer Prostatic Dis. 2011 Dec;14(4):346-53.

Tsivian M, Bañez LL, Keto CJ, et al. African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke Prostate Center. Prostate Cancer Prostatic Dis. 2013 Mar; 16(1):91-4.

Abern MR, Bassett MR, Tsivian M, Bañez LL, et al. Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center. Prostate Cancer Prostatic Dis. 2013 Mar; 16(1):85-90.

Singh AA, Jones LW, Antonelli JA, Gerber L, Calloway EE, Shuler KS, Freedland SJ, Grant DJ, Hoyo C, Bañez LL. Association Between Exercise and Primary Incidence of Prostate Cancer – Does Race Matter? Cancer. 2013 Apr 1;119(7):1338-43.

Updated: 11/06/13